drug
CKD Program
Preclinicalupdated 5mo agoby Arch Biopartners Inc
Preclinicalcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
News(2)
- Novo’s blockbuster hopes for CKD program dwindle after more phase 3 trials scrappedNovo Nordisk has given up on two more phase 3 trials of ziltivekimab, further eroding prospects for a molecule analysts once tipped as a potential blockbuster.fiercebiotech · 28d ago
- Novo Nordisk left praying to Artemis and Hermes to salvage CKD program after phase 3 failA phase 3 trial of Novo Nordisk’s ziltivekimab has missed its primary endpoint, denting the prospects of a molecule analysts tipped to generate blockbuster sales and diversify the company’s portfol…fiercebiotech · 2mo ago
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that